315 related articles for article (PubMed ID: 20816854)
41. IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.
Volkó J; Kenesei Á; Zhang M; Várnai P; Mocsár G; Petrus MN; Jambrovics K; Balajthy Z; Müller G; Bodnár A; Tóth K; Waldmann TA; Vámosi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21120-21130. PubMed ID: 31570576
[TBL] [Abstract][Full Text] [Related]
42. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.
Miyazaki T; Kawahara A; Fujii H; Nakagawa Y; Minami Y; Liu ZJ; Oishi I; Silvennoinen O; Witthuhn BA; Ihle JN
Science; 1994 Nov; 266(5187):1045-7. PubMed ID: 7973659
[TBL] [Abstract][Full Text] [Related]
43. Synthetic peptides as putative therapeutic agents in transplantation medicine: application of PEPSCAN to the identification of functional sequences in the extracellular domain of the interleukin-2 receptor beta chain (IL-2Rbeta).
Dionyssopoulou H; Mouzaki A; Slootstra J; Puijk W; Meloen R; Cordopatis P; Sotiropoulou G
J Immunol Methods; 2000 Jul; 241(1-2):83-95. PubMed ID: 10915851
[TBL] [Abstract][Full Text] [Related]
44. A membrane-proximal region of the interleukin-2 receptor gamma c chain sufficient for Jak kinase activation and induction of proliferation in T cells.
Nelson BH; Lord JD; Greenberg PD
Mol Cell Biol; 1996 Jan; 16(1):309-17. PubMed ID: 8524310
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response.
Rose T; Pillet AH; Lavergne V; Tamarit B; Lenormand P; Rousselle JC; Namane A; Thèze J
J Biol Chem; 2010 May; 285(20):14898-14908. PubMed ID: 20167604
[TBL] [Abstract][Full Text] [Related]
46. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
[TBL] [Abstract][Full Text] [Related]
47. Surface and intracellular interleukin-2 receptor expression on various resting and activated populations involved in cell-mediated immunity in human peripheral blood.
Hodge S; Hodge G; Flower R; Han P
Scand J Immunol; 2000 Jan; 51(1):67-72. PubMed ID: 10632978
[TBL] [Abstract][Full Text] [Related]
48. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
Chen M; Cheng A; Chen YQ; Hymel A; Hanson EP; Kimmel L; Minami Y; Taniguchi T; Changelian PS; O'Shea JJ
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6910-5. PubMed ID: 9192665
[TBL] [Abstract][Full Text] [Related]
49. Protein phosphatase 1 is involved in IL-2-induced IL-5 and IL-13 expression in human T cells.
Yamaoka K; Kaminuma O; Kitamura N; Mori A; Tatsumi H; Nemoto S; Hiroi T
Genes Cells; 2012 Jul; 17(7):611-8. PubMed ID: 22646506
[TBL] [Abstract][Full Text] [Related]
50. Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation.
Migone TS; Rodig S; Cacalano NA; Berg M; Schreiber RD; Leonard WJ
Mol Cell Biol; 1998 Nov; 18(11):6416-22. PubMed ID: 9774657
[TBL] [Abstract][Full Text] [Related]
51. Possible mechanism for the alpha subunit of the interleukin-2 receptor (CD25) to influence interleukin-2 receptor signal transduction.
Ellery JM; Nicholls PJ
Immunol Cell Biol; 2002 Aug; 80(4):351-7. PubMed ID: 12121224
[TBL] [Abstract][Full Text] [Related]
52. Expression, purification, refolding, and characterization of octreotide-interleukin-2: a chimeric tumor-targeting protein.
Jiang J; Deng L; He L; Liu H; Wang C
Int J Mol Med; 2011 Oct; 28(4):549-56. PubMed ID: 21687929
[TBL] [Abstract][Full Text] [Related]
53. Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor alpha-chain predicts a poor prognosis.
Nakase K; Kita K; Miwa H; Nishii K; Shikami M; Tanaka I; Tsutani H; Ueda T; Nasu K; Kyo T; Dohy H; Shiku H; Katayama N
Leukemia; 2007 Feb; 21(2):326-32. PubMed ID: 17205058
[TBL] [Abstract][Full Text] [Related]
54. IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.
Treiber-Held S; Stewart DM; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Apr; 79(1):71-8. PubMed ID: 8612353
[TBL] [Abstract][Full Text] [Related]
55. Biochemical analysis of interleukin-2 receptor beta chain phosphorylation by p56(lck).
Delespine-Carmagnat M; Bouvier G; Allée G; Fagard R; Bertoglio J
FEBS Lett; 1999 Mar; 447(2-3):241-6. PubMed ID: 10214954
[TBL] [Abstract][Full Text] [Related]
56. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
Lokau J; Petasch LM; Garbers C
Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
[TBL] [Abstract][Full Text] [Related]
57. Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits.
Roessler E; Grant A; Ju G; Tsudo M; Sugamura K; Waldmann TA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3344-7. PubMed ID: 8159750
[TBL] [Abstract][Full Text] [Related]
58. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15.
Ring AM; Lin JX; Feng D; Mitra S; Rickert M; Bowman GR; Pande VS; Li P; Moraga I; Spolski R; Ozkan E; Leonard WJ; Garcia KC
Nat Immunol; 2012 Dec; 13(12):1187-95. PubMed ID: 23104097
[TBL] [Abstract][Full Text] [Related]
59. Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.
Ross JA; Cheng H; Nagy ZS; Frost JA; Kirken RA
J Biol Chem; 2010 Feb; 285(6):3582-3591. PubMed ID: 19923221
[TBL] [Abstract][Full Text] [Related]
60. Construction of unnatural heterodimeric receptors based on IL-2 and IL-6 receptor subunits.
Ogawa K; Kawahara M; Nagamune T
Biotechnol Prog; 2013; 29(6):1512-8. PubMed ID: 23926072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
